Denali Therapeutics upgraded to Buy from Hold at Stifel
Stifel upgraded Denali Therapeutics (DNLI) to Buy from Hold with a $37 price target Denali recently aligned with the FDA to file for accelerated approval for their lead candidate DLN310/tividenofusp alfa in MPS IIA/Hunter syndrome with a BLA submission expected early-2025,
ServiceNow (NYSE:NOW) and an array of other software firms should prosper in 2025 due to a combination of monetizing ...
Stifel Financial Corp lifted its holdings in Spire Global, Inc. (NYSE:SPIR – Free Report) by 45.7% during the 3rd quarter, ...
Stifel raised the firm’s price target on Birkenstock (BIRK) to $70 from $63 and keeps a Buy rating on the shares. The company’s Q4 results and ...
Cloudflare stock was rising Tuesday after a Stifel analyst upgraded shares of the cybersecurity company, citing confidence in ...
As market dynamics evolve, alternative assets like art and collectibles will be promoted but, like all alternative ...
The Stifel Snow Show continues to bring fans unparalleled access to every sport on the FIS World Cup circuit, including ...
Stubborn inflation and a slowing economy will cause the S&P 500 to decline next year, one strategist forecasts.
Stifel lowered the firm’s price target on Sage Therapeutics (SAGE) to $6 from $10 and keeps a Hold rating on the shares. 2024 was “a challenging year,” with shares down about 75% following the failure ...
24/7 Wall St. on MSN5d
One of Wall Street's Top Gurus Predicts 2025 Sell-Off: The S&P 500 Could Plunge to 5500One renowned Wall Street analyst predicts that shrinking GDP and persistent inflation will result in a stock market ...
Hayward Holdings Inc (HAYW) stock saw a decline, ending the day at $16.08 which represents a decrease of $-0.11 or -0.68% from the prior close of $16.19. The stock opened at $16.13 and touched a low ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback